Siva Dallavalasa

441 total citations
13 papers, 276 citations indexed

About

Siva Dallavalasa is a scholar working on Infectious Diseases, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Siva Dallavalasa has authored 13 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Siva Dallavalasa's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Vitamin D Research Studies (2 papers). Siva Dallavalasa is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Vitamin D Research Studies (2 papers). Siva Dallavalasa collaborates with scholars based in India, United States and Australia. Siva Dallavalasa's co-authors include SubbaRao V. Madhunapantula, Narasimha M. Beeraka, Gjumrakch Aliev, Ravindra P. Veeranna, Upendarrao Golla, Preethi G. Anantharaju, Devesh Tewari, Malakapogu Ravindra Babu, Gaurav Gupta and Vinay Kumar Rao and has published in prestigious journals such as SHILAP Revista de lepidopterología, Current Medicinal Chemistry and Cancers.

In The Last Decade

Siva Dallavalasa

12 papers receiving 273 citations

Peers

Siva Dallavalasa
Eun‐Yup Lee South Korea
Jacob Cardenas United States
Jae-Hee Ahn South Korea
Baokun He China
Lang Bu China
Vincent Nganga United States
Eun‐Yup Lee South Korea
Siva Dallavalasa
Citations per year, relative to Siva Dallavalasa Siva Dallavalasa (= 1×) peers Eun‐Yup Lee

Countries citing papers authored by Siva Dallavalasa

Since Specialization
Citations

This map shows the geographic impact of Siva Dallavalasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Siva Dallavalasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Siva Dallavalasa more than expected).

Fields of papers citing papers by Siva Dallavalasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Siva Dallavalasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Siva Dallavalasa. The network helps show where Siva Dallavalasa may publish in the future.

Co-authorship network of co-authors of Siva Dallavalasa

This figure shows the co-authorship network connecting the top 25 collaborators of Siva Dallavalasa. A scholar is included among the top collaborators of Siva Dallavalasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Siva Dallavalasa. Siva Dallavalasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Dallavalasa, Siva, et al.. (2024). SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study. SHILAP Revista de lepidopterología. 12(7). 143–143.
2.
Dallavalasa, Siva, Preethi G. Anantharaju, R. Rajalakshmi, et al.. (2024). Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies. Cancers. 16(18). 3211–3211. 8 indexed citations
3.
Dallavalasa, Siva, et al.. (2023). Quercetin activates vitamin D receptor and ameliorates breast cancer induced hepatic inflammation and fibrosis. Frontiers in Nutrition. 10. 1158633–1158633. 19 indexed citations
4.
Dallavalasa, Siva, et al.. (2023). COVID-19: Diabetes Perspective—Pathophysiology and Management. Pathogens. 12(2). 184–184. 21 indexed citations
6.
Harish, Vancha, Devesh Tewari, Malakapogu Ravindra Babu, et al.. (2022). Quality by Design Based Formulation of Xanthohumol Loaded Solid Lipid Nanoparticles with Improved Bioavailability and Anticancer Effect against PC-3 Cells. Pharmaceutics. 14(11). 2403–2403. 23 indexed citations
7.
Beeraka, Narasimha M., Siva Dallavalasa, Yaowen Zhang, et al.. (2022). COVID-19 Effects on Geriatric Population and Failures of AminoquinolineTherapy: Compilation of Studies from EU, USA, and China;Safety and Efficacy of Vaccines in the Prevention and Treatment ofCOVID-19. Current Medicinal Chemistry. 29(20). 3601–3621. 5 indexed citations
8.
Dallavalasa, Siva, et al.. (2022). Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness. Vaccines. 10(10). 1751–1751. 14 indexed citations
9.
Dallavalasa, Siva, et al.. (2022). Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients. Vaccines. 10(7). 1125–1125. 8 indexed citations
10.
Golla, Upendarrao, et al.. (2022). ABHD11-AS1: An Emerging Long Non-Coding RNA (lncRNA) with Clinical Significance in Human Malignancies. Non-Coding RNA. 8(2). 21–21. 13 indexed citations
11.
Golla, Upendarrao & Siva Dallavalasa. (2022). Chemopreventive Effects of Selenium and Selenocompounds in the Treatment of Lymphoma. MDPI (MDPI AG). 2(3). 310–327. 3 indexed citations
12.
Dallavalasa, Siva. (2021). The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status. Current Medicinal Chemistry. 28(39). 8203–8236. 5 indexed citations
13.
Dallavalasa, Siva, et al.. (2021). The Role of Tumor Associated Macrophages (TAMs) in Cancer Progression, Chemoresistance, Angiogenesis and Metastasis - Current Status. Current Medicinal Chemistry. 28(39). 8203–8236. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026